POP-7 inhibitors are a class of chemical compounds that interact with the enzyme prolyl oligopeptidase, commonly referred to as POP or PREP. This enzyme belongs to the family of serine proteases and is primarily involved in cleaving peptide bonds at the carboxyl side of proline residues in short peptides, typically less than 30 amino acids in length. POP is found in various tissues, and it plays an essential role in the regulation of several physiological processes by modulating peptide signaling pathways. The structure of POP includes a β-propeller domain and a catalytic serine domain, where its proteolytic activity takes place. POP-7 inhibitors are designed to target the active site of the enzyme, interfering with its ability to process peptides, which can have broad implications on peptide metabolism. The precise mechanism by which these inhibitors bind can vary, but they typically act by forming reversible or irreversible complexes with the catalytic triad of the enzyme.
The chemical design of POP-7 inhibitors often incorporates features that mimic the transition state of peptide cleavage, enhancing their specificity for the enzyme. These inhibitors can be small molecules or larger, more complex scaffolds that interact not only with the catalytic site but also with the surrounding structural elements of the enzyme, influencing its conformational flexibility. Structural studies of POP-7 inhibitors reveal that these compounds often bind within the β-propeller region, which modulates access to the catalytic domain, thereby providing an additional layer of regulation. This structural interplay allows for a high degree of selectivity in inhibiting POP, a crucial factor given the enzyme's ubiquitous presence in various tissues. Furthermore, the development of POP-7 inhibitors can involve the careful consideration of factors such as solubility, stability, and molecular geometry to ensure precise targeting of POP without off-target effects on other proteases.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A could promote histone acetylation, potentially leading to a tightly wound chromatin state that reduces the transcription of the POP-7 gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine may lead to hypomethylation of the POP-7 gene promoter, which could decrease POP-7 mRNA synthesis and subsequent protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By binding to and inhibiting mTOR, Rapamycin could downregulate the initiation of mRNA translation, potentially leading to reduced synthesis of the POP-7 protein. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds specifically to DNA at the transcription initiation complex, obstructing RNA polymerase action, which could decrease POP-7 mRNA production. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide impedes eukaryotic protein elongation during translation by inactivating the ribosome, which could lead to a decrease in POP-7 protein synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal acidification and autophagy, which could decrease the stability and expression of the POP-7 protein by altering post-translational modifications. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through retinoic acid receptors, can initiate transcriptional repression of certain genes, potentially leading to the downregulation of POP-7 expression. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone could competitively bind to mineralocorticoid receptors, leading to transcriptional changes that may result in a decrease in POP-7 mRNA levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to suppress the activation of transcription factors such as NF-κB, which could lead to the downregulation of POP-7 expression at the transcriptional level. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol's activation of sirtuins may lead to the deacetylation of histones associated with the POP-7 gene, potentially resulting in decreased transcription and protein expression. | ||||||